PharmaShots | Incisive News in 3 Shots

Subscribe Now

Similis Bio

Similis Bio Collaboration with Novel351k to Develop Multiple Biosimilar Programs for Cancer and Autoimmune Diseases

Similis Bio Collaboration with Novel351k to Develop Multiple Biosimilar Programs for Cancer and Autoimmune Diseases

February 14, 2023

Similis Bio Entered into a Development and License Agreement with Blau Farmaceutica to Co-Develop Four Biosimilar Programs

Similis Bio Entered into a Development and License Agreement with Blau Farmaceutica to Co-Develop Four Biosimilar Programs

October 25, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us